Metraipolis › archive › dc_0ad23c73fa60

Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI-treated NSCLC: a cross-database real-world study — Europe PMC PMID:42656595

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42656595
DOI
10.3389/fphar.2026.1789598
License (as archived)
solo-consultazione
Archived
2026-10-08T17:09:05.358Z
SHA-256 of the archived text
e2cc2b302bfbc6b81ff4a35395dbb16e8ebd88e7da2cd6a28e0d1ae5eb63851f
Stable URL of this page
https://metraipolis.com/documento/dc_0ad23c73fa60

How to cite

Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI-treated NSCLC: a cross-database real-world study — Europe PMC PMID:42656595 — Europe PMC (en), https://europepmc.org/article/MED/42656595 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ad23c73fa60 (Metraipolis archive dc_0ad23c73fa60, sha256 e2cc2b302bfbc6b81ff4a35395dbb16e8ebd88e7da2cd6a28e0d1ae5eb63851f)
BibTeX
@misc{dc0ad23c73fa60,
  title = {Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI-treated NSCLC: a cross-database real-world study — Europe PMC PMID:42656595},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42656595},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ad23c73fa60; sha256 e2cc2b302bfbc6b81ff4a35395dbb16e8ebd88e7da2cd6a28e0d1ae5eb63851f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42656595. Agents can read the archived copy with the MCP tool read_document.